Cent Eur J Public Health 2014, 22(4):282-286 | DOI: 10.21101/cejph.a4010

Seroprevalence of Rubella Antibodies among Adult Egyptian Females Aged 20-30 Years. Is there a Need for Rubella Vaccination?

Mohsen Gadallah1, Nasr El Sayed2, Amr Kandeel2, Ibrahim Moussa2, Amira Mohsen3, Sahar Dewedar1
1 Faculty of Medicine, Ain Shams University, Cairo, Egypt
2 Ministry of Health and Population, Cairo, Egypt
3 Department of Community Medicine, National Research Center, Cairo, Egypt

Introduction: Egypt adopted a comprehensive strategy to eliminate measles and rubella by conducting a catch up campaign (in 2008) targeting children and young adults in the age group 10-19 years. This study aimed to explore the seroprevalence of rubella among females aged 20 to 30 years in order to provide the Ministry of Health with information to develop future strategies for rubella supplemental immunization activities among women of childbearing age before marriage and conception.

Methods: A total of 339 females in the age group 20 to 30 were selected. The study group comprised women who attended the central laboratory of the Ministry of Health for checking up before travelling abroad as pre-travel requirements for visa application. The collected serum samples were tested for rubella-specific IgG antibodies.

Results: The overall prevalence of rubella antibodies in the study group was 88.2%. Around 5.0% of females, who reported that they had been vaccinated, were susceptible to rubella. Age, history of measles, mumps and rubella (MMR) vaccination and past history of rubella infection were considered factors associated with seropositivity for rubella.

Conclusion: The seroprevalence rate of rubella antibodies among our female study group was considered low.

Keywords: seroprevalence, rubella, rubella campaigns, rubella vaccine

Received: February 1, 2014; Revised: July 25, 2014; Accepted: July 25, 2014; Published: December 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Gadallah M, El Sayed N, Kandeel A, Moussa I, Mohsen A, Dewedar S. Seroprevalence of Rubella Antibodies among Adult Egyptian Females Aged 20-30 Years. Is there a Need for Rubella Vaccination? Cent Eur J Public Health. 2014;22(4):282-286. doi: 10.21101/cejph.a4010. PubMed PMID: 25622490.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Centers for Disease Control and Prevention (CDC). Elimination of rubella and congenital rubella syndrome - United States, 1969-2004. MMWR Morb Mortal Wkly Rep. 2005 Mar 25;54(11):279-82.
    2. World Health Organization. Global measles and rubella: strategic plan 2012-2020 [Internet]. Geneva: WHO; 2012 [cited 2014 Jul 25]. Available from: http://www.who.int/immunization/newsroom/Measles_Rubella_StrategicPlan_2012_2020.pdf.
    3. UNICEF. Immunization. Towards a world without measles and rubella [Internet]. UNICEF; 2014 [cited 2014 Jul 25]. Available from: http://www.unicef.org/immunization/index_measles.html.
    4. Centers for Disease Control and Prevention (CDC). Progress toward control of rubella and prevention of congenital rubella syndrome - worldwide, 2009. MMWR Morb Mortal Wkly Rep. 2010 Oct 15;59(40):1307-10.
    5. El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JP Jr, Naouri B, et al. Progress toward measles and rubella elimination in Egypt. J Infect Dis. 2011 Jul;204 Suppl 1:S318-24. Go to original source... Go to PubMed...
    6. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J. 2007 Dec;26(12):1137-41. Go to original source... Go to PubMed...
    7. Centers for Disease Control and Prevention (CDC). Nationwide campaign for vaccination of adults against rubella and measles - Costa Rica, 2001. MMWR Morb Mortal Wkly Rep. 2001 Nov 9;50(44):976-9.
    8. Artimos de Oliveira S, Bastos Camacho LA, Uzeda Barreto MC, Coca Velarde LG, Siqueira MM. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data. J Infect Dis. 2011 Sep 1;204 Suppl 2:S664-8. Go to original source... Go to PubMed...
    9. Honarvar B, Moghadami M, Moattari A, Emami A, Odoomi N, Bagheri Lankarani K. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign. PLoS One. 2013;8(1):e55043. Go to original source... Go to PubMed...
    10. YounesAT, ElianA, Darwish MA. Rubella virus antibodies in women of childbearing age. J Egypt Public Health Assoc. 1991;66(3-4):397-410. Go to PubMed...
    11. Hashem M, Husein MH, Saleh DA,Abdelhai R, Eltahlawy E, Esmat H, et al. Rubella: serosusceptibility among Egyptian females in late childhood and childbearing period. Vaccine. 2010 Oct 18;28(44):7202-6. Go to original source... Go to PubMed...
    12. Senèze C, Haus-Cheymol R, Hanslik T. Rubella seroprevalence in 234 military young women aged between 19 and 31 years. Presse Med. 2008 Dec;37(12):1717-22. (In French.) Go to original source... Go to PubMed...
    13. Dayan GH, Panero MS, UrquizaA, Molina M, Prieto S, Del Carmen Perego M, et al. Rubella and measles seroprevalence among women of childbearing age, Argentina, 2002. Epidemiol Infect. 2005 Oct;133(5):861-9. Go to original source... Go to PubMed...
    14. Aksakal FN, Maral I, Cirak MY,Aygun R. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey? Jpn J Infect Dis. 2007 Jul;60(4):157-60.
    15. Pehlivan E, Karaoglu L, Ozen M, Gunes G, Tekerekoglu MS, Genc MF, et al. Rubella seroprevalence in an unvaccinated pregnant population in Malatya, Turkey. Public Health. 2007 Jun;121(6):462-8. Go to original source... Go to PubMed...
    16. Seker S, Abasiyanik MF, Salih BA. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey. Saudi Med J. 2004 May;25(5):575-9.
    17. Langiano E, Ferrara M, Lanni L, Atrei P, Martellucci G, De Vito E. Rubella seroprevalence in childbearing age women: a cross sectional study in the province of Frosinone, Central Southern Italy. Ital J Public Health. 2009;6(3):194-201.
    18. Su SB, Guo HR. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination. Am J Trop Med Hyg. 2002 Nov;67(5):549-53. Go to original source...
    19. Kumakura S, Shibata H, Onoda K, Nishimura N, Matsuda C, Hirose M. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy. Epidemiol Infect. 2014 Jan;142(1):12-9. Go to original source... Go to PubMed...
    20. Corcoran C, Hardie DR. Seroprevalence of rubella antibodies among antenatal patients in the Western Cape. SAfr Med J. 2005 Sep;95(9):68890.
    21. Bamgboye AE, Afolabi KA, Esumeh FI, Enweani IB. Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria. West Afr J Med. 2004 Jul-Sep;23(3):245-8. Go to original source...
    22. Kombich JJ, Muchai PC, Borus PK. Seroprevalence of natural rubella antibodies among antenatal attendees at Moi Teaching and Referral Hospital, Eldoret, Kenya. J Immunol Tech Infect Dis. 2012,1(1):1-4. Go to original source...
    23. Jarour N, Hayajneh WA, Balbeesi A, Otoom H, Al-Shurman A, Kharabsheh S. Seroprevalence of rubella among Jordanian women of childbearing age. Vaccine. 2007 May 4;25(18):3615-8. Go to original source... Go to PubMed...
    24. Al-Sheref F, Jefrri OH, El-Sayed ZMF. Seroprevalence of rubella among pregnant women and young females. Egypt J Med Microb. 2010 Jan;19(1):119-28.
    25. Caidi H, Bloom S, Azilmaat M, Benjouad A, Reef S, El Aouad R. Rubella seroprevalence among women aged 15-39 years in Morocco. East Mediterr Health J. 2009 May-Jun;15(3):526-31. Go to original source...
    26. Ouyahia A, Segueni A, Laouamri S, Touabti A, Lacheheb A. Seroprevalence of rubella among women of childbearing age in Algeria. Is there a need for a rubella vaccination? Int J Public Health Epidemiol. 2013 Jan;2(1):56-9.
    27. Wysokiñska T, Janaszek W, Bucholc B, Gorska P, Gniadek G, Slusarczyk J, et al. The prevalence of anti-rubella antibodies in women of childbearing age in Poland. Vaccine. 2004 May 7;22(15-16):1899-902. Go to original source... Go to PubMed...
    28. Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect. 2006 Dec;134(6):1303-12. Go to original source... Go to PubMed...
    29. Lim GH, Harris T, Desai S, Crowcroft NS, Mazzulli T, Kozlowski T, et al. Rubella immunity among prenatal women in Ontario, 2006-2010. BMC Infect Dis. 2013 Aug 2;13:362. Go to original source... Go to PubMed...
    30. Wang IJ, Huang LM, Chen HH, Hwang KC, Chen CJ. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact. J Med Virol. 2007 Jan;79(1):97-103. Go to original source... Go to PubMed...

    Return to the content